The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis

Adams, 1983, Mercury intoxication simulating amyotrophic lateral sclerosis, JAMA, 250, 642, 10.1001/jama.1983.03340050054029

Adkins, 1993, Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes, Am J Hum Genet, 53, 598

Albalak, 2003, Blood lead levels and risk factors for lead poisoning among children in a Mexican smelting community, Arch Environ Health, 58, 172

Albanito, 2008, G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells, Environ Health Perspect, 116, 1648, 10.1289/ehp.11297

Arvidson, 1992, Inorganic mercury is transported from muscular nerve terminals to spinal and brainstem motoneurons, Muscle Nerve, 15, 1089, 10.1002/mus.880151006

Bakir, 1973, Methylmercury poisoning in Iraq, Science, 181, 230, 10.1126/science.181.4096.230

Barbeito AG, Guelfi N, Varga MR, Pehar M, Beckman J, Barbeito L, et al. Chronic low-level lead exposure increases survival of G93A SOD-1 transgenic mice [Abstract]. In: Amyotrophic lateral sclerosis: beyond the motor neuron; 2005. Available: http://iibce.edu.uy/alsmeeting/abstract.htm (Accessed December, 2008).

Barber, 1978, Inorganic mercury intoxication reminiscent of amyotrophic lateral sclerosis, J Occup Med, 20, 667

Binns, 1999, Evaluation of risk assessment questions used to target blood lead screening in Illinois, Pediatrics, 103, 100, 10.1542/peds.103.1.100

Boillée, 2006, Onset and progression in inherited ALS determined by motor neurons and microglia, Science, 312, 1389, 10.1126/science.1123511

Brophy, 2001, Polymorphisms in the human paraoxonase (PON1) promoter, Pharmacogenetics, 11, 77, 10.1097/00008571-200102000-00009

Burge, 1994, Mercury contamination in Arkansas gamefish. A public health perspective, J Ark Med Soc, 90, 542

Campbell, 1970, Motor neurone disease and exposure to lead, J Neurol Neurosurg Psychiatry, 33, 877, 10.1136/jnnp.33.6.877

Chuu, 2007, Differential neurotoxic effects of methylmercury and mercuric sulfide in rats, Toxicol Lett, 169, 109, 10.1016/j.toxlet.2006.12.006

Cox, 2002, Cycad neurotoxins, consumption of flying foxes and ALS/PDC disease in Guam, Neurology, 58, 956, 10.1212/WNL.58.6.956

Cronin, 2007, Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis, J Neurol Neurosurg Psychiatry, 78, 984, 10.1136/jnnp.2006.112581

Diekstra, 2009, Interaction between PON1 and population density in amyotrophic lateral sclerosis, Neuroreport, 20, 186, 10.1097/WNR.0b013e32831af220

Donoghue, 1998, Mercury toxicity due to the smelting of placer gold recovered by mercury amalgam, Occup Med (Lond), 48, 413, 10.1093/occmed/48.6.413

Elbaz, 2007, Interaction between genes and environment in neurodegenerative diseases, C R Biol, 330, 318, 10.1016/j.crvi.2007.02.018

Ermilova, 2005, Protection by dietary zinc in ALS mutant G93A SOD transgenic mice, Neurosci Lett, 379, 42, 10.1016/j.neulet.2004.12.045

Foo, 1993, Metals in hair as biological indices for exposure, Int Arch Occup Environ Health, 65, S83, 10.1007/BF00381312

Furlong, 2005, Role of paraoxonase (PON1) status in pesticide sensitivity: genetic and temporal determinants, Neurotoxicology, 26, 651, 10.1016/j.neuro.2004.08.002

Furlong, 2000, Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1), Neurotoxicology, 21, 91

Galasko, 2002, 1997–2000 Clinical features and changing patterns of neurodegenerative disorders on Guam, Neurology, 58, 90, 10.1212/WNL.58.1.90

Grandjean, 1999, Methylmercury neurotoxicity in Amazonian children downstream from gold mining, Environ Health Perspect, 107, 587, 10.1289/ehp.99107587

Gresham, 1986, Amyotrophic lateral sclerosis and occupational heavy metal exposure: a case–control study, Neuroepidemiology, 5, 29, 10.1159/000110810

Groenevelda, 2003, Zinc amplifies mSOD1-mediated toxicity in a transgenic mouse model of amyotrophic lateral sclerosis, Neurosci Lett, 352, 175, 10.1016/j.neulet.2003.08.062

Gurney, 1997, Transgenic animal models of familial amyotrophic lateral sclerosis, J Neurol, 244, S15, 10.1007/BF03160575

Haley, 1996, Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans, Toxicol Appl Pharmacol, 157, 227, 10.1006/taap.1999.8703

Haley, 2003, Excess incidence of ALS in young Gulf War veterans, Neurology, 61, 750, 10.1212/WNL.61.6.750

Håkansson, 2003, Neurodegenerative diseases in welders and other workers exposed to high levels of magnetic fields, Epidemiology, 14, 420, 10.1097/01.EDE.0000078446.76859.c9

Henderson, 2002, Response of rats to low levels of sarin, Toxicol Appl Pharmacol, 184, 67, 10.1006/taap.2002.9495

Horner, 2008, Amyotrophic lateral sclerosis among 1991 Gulf War veterans: evidence for a time-limited outbreak, Neuroepidemiology, 31, 28, 10.1159/000136648

Iwami, 1993, Motor neuron disease on the Kii Peninsula of Japan: cycad exposure, Neuroepidemiology, 12, 307, 10.1159/000110332

Johnson, 2008, Potential enhanced development of paralytic phenotype in SOD1-G93a mice by methylmercury. Environmental etiologies of neurological disorders: scientific, translational and policy implications

Johnson, 2009, Postnatal exposure to methylmercury enhances development of paralytic phenotype in Sod1-G93a female mice. The toxicologist, supplement to Tox. Sci.

Kamel, 2008, Association of lead exposure with survival in amyotrophic lateral sclerosis, Environ Health Perspect, 116, 943, 10.1289/ehp.11193

Kamel, 2005, Lead exposure as a risk factor for amyotrophic lateral sclerosis, Neurodegener Dis, 2, 195, 10.1159/000089625

Kasarskis, 2009, Clinical aspects of ALS in Gulf War veterans, Amyotroph Lateral Scler, 10, 35, 10.1080/17482960802351029

Kisby, 1992, Content of the neurotoxins cycasin (methylazoxymethanol beta-d-glucoside) and BMAA (beta-N-methylaminol-alanine) in cycad flour prepared by Guam Chamorros, Neurology, 42, 1336, 10.1212/WNL.42.7.1336

Kurland, 1987, Age-specific incidence rates for motor neuron disease, J Neurol Neurosurg Psychiatry, 50, 115, 10.1136/jnnp.50.1.115

Kurlander, 1979, Metals in spinal cord tissue of patients dying of motor neuron disease, Ann Neurol, 6, 21, 10.1002/ana.410060105

Landers, 2008, A common haplotype within the PON1 promoter region is associated with sporadic ALS, Amyotroph Lateral Scler, 9, 306, 10.1080/17482960802233177

Leigh, 1991, Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity, Brain, 114, 775, 10.1093/brain/114.2.775

Li, 2000, Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds, Pharmacogenetics, 10, 767, 10.1097/00008571-200012000-00002

Li, 2003, Association between occupational exposure to power frequency electromagnetic fields and amyotrophic lateral sclerosis: a review, Am J Ind Med, 43, 212, 10.1002/ajim.10148

Lindgren, 2003, Pattern of blood lead levels over working lifetime and neuropsychological performance, Arch Environ Health, 58, 373

Longstreth, 1998, Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case–control study, Arch Neurol, 5, 201, 10.1001/archneur.55.2.201

Mackness, 2000, Low paraoxonase in Persian Gulf War Veterans self-reporting Gulf War Syndrome, Biochem Biophys Res Commun, 276, 729, 10.1006/bbrc.2000.3526

Martin, 1985, Striatal neurochemical changes and motor dysfunction in mipafox-treated animals, Methods Find Exp Clin Pharmacol, 7, 79

McGuire, 1997, Occupational exposures and amyotrophic lateral sclerosis. A population-based case–control study, Am J Epidemiol, 145, 1076, 10.1093/oxfordjournals.aje.a009070

Mahaffey, 2004, Blood organic mercury and dietary mercury intake: National Health and Nutrition Examination Survey, 1999 and 2000, Environ Health Perspect, 112, 562, 10.1289/ehp.6587

Miranda, 2008, Spatial analysis of the etiology of amyotrophic lateral sclerosis among 1991 Gulf War veterans, Neurotoxicology, 29, 964, 10.1016/j.neuro.2008.05.005

Morahan, 2007, A gene–environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis, Neurotoxicology, 28, 532, 10.1016/j.neuro.2006.11.007

Morahan, 2006, A gene–environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis, Neurotoxicology, 28, 532, 10.1016/j.neuro.2006.11.007

Morahan, 2006, Amyotrophic lateral sclerosis and exposure to environmental toxins: an Australian case–control study, Neuroepidemiology, 27, 130, 10.1159/000095552

Moriwaka, 1991, A clinical evaluation of the inorganic mercurialism—its pathogenic relation to amyotrophic lateral sclerosis, Rinsho Shinkeigaku, 31, 885

Morrison, 1999, Amyotrophic lateral sclerosis associated with mutations in superoxide dismutase: a putative mechanism of degeneration, Brain Res Rev, 29, 121, 10.1016/S0165-0173(98)00049-6

Murch, 2004, Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam, Acta Neurol Scand, 110, 267, 10.1111/j.1600-0404.2004.00320.x

Mutter, 2008, Kawasaki's disease, acrodynia, and mercury, Curr Med Chem, 15, 3000, 10.2174/092986708786848712

Nelson, 2000, Population-based case–control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption, Am J Epidemiol, 151, 156, 10.1093/oxfordjournals.aje.a010183

Pamphlett, 1998, Mercury in human spinal motor neurons, Acta Neuropathol (Berl), 96, 515, 10.1007/s004010050927

Pierce-Ruhland, 1980, Muscle metals in motor neuron disease, Ann Neurol, 8, 193, 10.1002/ana.410080211

Plato, 2003, ALS and PDC of Guam: forty-year follow-up, Neurology, 58, 765, 10.1212/WNL.58.5.765

Plato, 2003, Amyotrophic lateral sclerosis and parkinsonism–dementia complex of Guam: changing incidence rates during the past 60 years, Am J Epidemiol, 157, 149, 10.1093/aje/kwf175

Poulletier de Gannes, 2008, Amyotrophic lateral sclerosis (ALS) and extremely-low frequency (ELF) magnetic fields: a study in the SOD-1 transgenic mouse model, Amyotroph Lateral Scler, 1, 10.1080/17482960802320396

Praline, 2007, Case report; ALS and mercury intoxication: a relationship?, Clin Neurol Neurosurg, 109, 880, 10.1016/j.clineuro.2007.07.008

Provinciali, 1990, Antecedent events in amyotrophic lateral sclerosis: do they influence clinical onset and progression?, Neuroepidemiology, 9, 255, 10.1159/000110782

Qureshi, 2008, Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS), Amyotroph Lateral Scler, 7, 173, 10.1080/14660820600640596

Richter, 2009, Paraoxonase 1 (PON1) status and substrate hydrolysis, Toxicol Appl Pharmacol, 235, 1, 10.1016/j.taap.2008.11.001

Roscoe, 2002, Adult blood lead epidemiology and surveillance—United States, 1998–2001, MMWR Surveill Summ, 13, 1

Rosen, 1993, Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, 362, 59, 10.1038/362059a0

Rustam, 1975, Evidence for a neuromuscular disorder in methylmercury poisoning, Arch Environ Health, 30, 190, 10.1080/00039896.1975.10666674

Sacks, 1993, Guam ALS–PDC: possible causes, Science, 262, 826, 10.1126/science.8235600

Saeed, 2006, Paraoxonase cluster polymorphisms are associated with sporadic ALS, Neurology, 67, 771, 10.1212/01.wnl.0000227187.52002.88

Schmidt, 2008, Genes and environmental exposures in veterans with amyotrophic lateral sclerosis: the GENEVA study. Rationale, study design and demographic characteristics, Neuroepidemiology, 30, 191, 10.1159/000126911

Schwarz, 1996, Amyotrophic lateral sclerosis after accidental injection of mercury, J Neurol Neurosurg Psychiatry, 60, 698, 10.1136/jnnp.60.6.698

Schymick, 2007, Genetics of sporadic amyotrophic lateral sclerosis, Hum Mol Genet, 16, 10.1093/hmg/ddm215

Sejvar, 2005, Amyotrophic lateral sclerosis mortality in the United States, 1979–2000, Neuroepidemiology, 25, 144, 10.1159/000086679

Shoesmith, 2006, Amyotrophic lateral sclerosis: update for family physicians, Can Fam Physician, 52, 1563

Sienko, 1990, Amyotrophic lateral sclerosis. A case–control study following detection of a cluster in a small Wisconsin community, Arch Neurol, 47, 38, 10.1001/archneur.1990.00530010046017

Simpson, 2006, Amyotrophic lateral sclerosis as a complex genetic disease, Biochim Biophys Acta, 1762, 973, 10.1016/j.bbadis.2006.08.001

Sirivarasai, 2007, Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects, Chem Biol Interact, 20, 184, 10.1016/j.cbi.2007.04.006

Slowik, 2006, Paraoxonase gene polymorphisms and sporadic ALS, Neurology, 67, 766, 10.1212/01.wnl.0000219565.32247.11

Spencer, 1987, Cycad use and motor neurone disease in Irian Jaya, Lancet, 2, 1462, 10.1016/S0140-6736(87)91159-7

Stozická, 2007, Risk and protective factors for sporadic Alzheimer's disease, Acta Virol, 51, 205

Sutedja, 2008, Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review, Amyotroph Lateral Scler, 8, 1

Thakur, 2008, Epidemiological study of high cancer among rural agricultural community of Punjab in Northern India, Int J Environ Res Public Health, 5, 399, 10.3390/ijerph5050399

The Riegle Report (accessed January 1, 2008). US chemical and biological warfare-related dual use exports to Iraq and their possible impact on health consequences of the Gulf War. Committee on Banking Housing and Urban Affairs with respect to export administration; 1994. http://www.gulfweb.org/bigdoc/report/riegle1.html.

Valdmanis, 2008, Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and Sweden, Neurology, 71, 514, 10.1212/01.wnl.0000324997.21272.0c

Veldink, 2005, Physical activity and the association with sporadic ALS, Neurology, 64, 241, 10.1212/01.WNL.0000149513.82332.5C

Waring, 2004, Incidence of amyotrophic lateral sclerosis and of the parkinsonism–dementia complex of Guam, 1950–1989, Neuroepidemiology, 23, 192, 10.1159/000078505

Worms, 2001, The epidemiology of motor neuron disease: a review of recent studies, J Neurol Sci, 191, 3, 10.1016/S0022-510X(01)00630-X

Weiss, 2004, Pesticides, Pediatrics, 113, 10.1542/peds.113.S3.1030

Weisskopf, 2009, Prospective study of chemical exposures and amyotrophic lateral sclerosis, J Neurol Neurosurg Psychiatry, 80, 558, 10.1136/jnnp.2008.156976

Weisskopf, 2004, Prospective study of cigarette smoking and amyotrophic lateral sclerosis, Am J Epidemiol, 160, 26, 10.1093/aje/kwh179

Wills, 2008, Paraoxonase 1(PON1) organophosphate hydrolysis is not reduced in ALS, Neurology, 70, 929, 10.1212/01.wnl.0000305956.37931.dd

Yan, 2008, Excitatory effects of low-level lead exposure on action potential firing of pyramidal neurons in CA1 region of rat hippocampal slices, J Neurosci Res, 86, 3665, 10.1002/jnr.21804

Zumstein, 1982, Amyotrophic lateral sclerosis. Epidemiologic study, Schweiz Rundsch Med Prax, 14, 1424